The weekly litigation news digest is live. Subscribe now
Indazole Compounds As Irak4 Inhibitors - EP3092226
The patent EP3092226 was granted to Aurigene Discovery on Mar 13, 2019. The application was filed on Jan 7, 2015 under application number EP15703102A. The patent is currently recorded with a legal status of "Revoked".
EP3092226
- Application Number
- EP15703102A
- Filing Date
- Jan 7, 2015
- Status
- Revoked
- Jan 15, 2021
- Publication Date
- Mar 13, 2019
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (10) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents